Pediatric Craniopharyngioma Differential Diagnoses

1. Prabhu VC, Brown HG. The pathogenesis of craniopharyngiomas. Childs Nerv Syst. 2005 Aug. 21(8-9):622-7. [QxMD MEDLINE Link].

2. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun. 131 (6):803-20. [QxMD MEDLINE Link].

3. Omay SB, Chen YN, Almeida JP, Ruiz-Treviño AS, Boockvar JA, Stieg PE, et al. Do craniopharyngioma molecular signatures correlate with clinical characteristics?. J Neurosurg. 2018 May. 128 (5):1473-1478. [QxMD MEDLINE Link].

4. Garre ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007 Aug. 19(4):471-9. [QxMD MEDLINE Link].

5. Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014 Feb. 46 (2):161-5. [QxMD MEDLINE Link].

6. Hofmann BM, Kreutzer J, Saeger W, et al. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol. 2006 Dec. 30(12):1595-603. [QxMD MEDLINE Link].

7. Malgulwar PB, Nambirajan A, Pathak P, Faruq M, Suri V, Sarkar C, et al. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. J Neurooncol. 2017 Jul. 133 (3):487-495. [QxMD MEDLINE Link].

8. Donson AM, Apps J, Griesinger AM, et al. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma. J Neuropathol Exp Neurol. 2017 Sep 1. 76 (9):779-788. [QxMD MEDLINE Link].

9. Pettorini BL, Frassanito P, Caldarelli M, Tamburrini G, Massimi L, Di Rocco C. Molecular pathogenesis of craniopharyngioma: switching from a surgical approach to a biological one. Neurosurg Focus. 2010 Apr. 28(4):E1. [QxMD MEDLINE Link].

10. Coury JR, Davis BN, Koumas CP, Manzano GS, Dehdashti AR. Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev. 2018 Apr 17. [QxMD MEDLINE Link].

11. Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005 Aug. 21(8-9):640-8. [QxMD MEDLINE Link].

12. Müller HL. Childhood craniopharyngioma. Pituitary. 2012 Jun 8. [QxMD MEDLINE Link].

13. Karavitaki N, Wass JA. Craniopharyngiomas. Endocrinol Metab Clin North Am. 2008 Mar. 37(1):173-93, ix-x. [QxMD MEDLINE Link].

14. Makino K, Nakamura H, Yano S, Kuratsu J. Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst. 2010 Aug. 26(8):1029-34. [QxMD MEDLINE Link].

15. Pan J, Qi S, Liu Y, Lu Y, Peng J, Zhang X, et al. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients. J Neurosurg Pediatr. 2016 Apr. 17 (4):418-33. [QxMD MEDLINE Link].

16. Jakacki RI, Cohen BH, Jamison C, et al. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. J Neurosurg. 2000 Feb. 92(2):255-60. [QxMD MEDLINE Link].

17. Yeung JT, Pollack IF, Panigrahy A, Jakacki RI. Pegylated interferon-a-2b for children with recurrent craniopharyngioma. J Neurosurg Pediatr. 2012 Dec. 10(6):498-503. [QxMD MEDLINE Link].

18. Mrowczynski OD, Langan ST, Rizk EB. Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape. Clin Neurol Neurosurg. 2018 Mar. 166:124-130. [QxMD MEDLINE Link].

19. Takahashi H, Yamaguchi F, Teramoto A. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst. 2005 Aug. 21(8-9):701-4. [QxMD MEDLINE Link].

20. Zhang S, Fang Y, Cai BW, Xu JG, You C. Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev. 2016 Jul 14. 7:CD008890. [QxMD MEDLINE Link].

21. Cavalheiro S, Dastoli PA, Silva NS, Toledo S, Lederman H, da Silva MC. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst. 2005 Aug. 21 (8-9):719-24. [QxMD MEDLINE Link].

22. Laws ER Jr, Morris AM, Maartens N. Gliadel for pituitary adenomas and craniopharyngiomas. Neurosurgery. 2003 Aug. 53(2):255-69; discussion 259-60. [QxMD MEDLINE Link].

23. Bakhsheshian J, Jin DL, Chang KE, Strickland BA, Donoho DA, Cen S, et al. Risk factors associated with the surgical management of craniopharyngiomas in pediatric patients: analysis of 1961 patients from a national registry database. Neurosurg Focus. 2016 Dec. 41 (6):E8. [QxMD MEDLINE Link].

24. Lin Y, Hansen D, Sayama CM, Pan IW, Lam S. Transfrontal and Transsphenoidal Approaches to Pediatric Craniopharyngioma: A National Perspective. Pediatr Neurosurg. 2017 Feb 23. [QxMD MEDLINE Link].

25. Baskin DS, Wilson CB. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg. 1986 Jul. 65(1):22-7. [QxMD MEDLINE Link].

26. Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990 Jul. 73(1):3-11. [QxMD MEDLINE Link].

27. Clark AJ, Cage TA, Aranda D, Parsa AT, Sun PP, Auguste KI, et al. A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst. 2013 Feb. 29(2):231-8. [QxMD MEDLINE Link].

28. Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr. 2010 Jan. 5(1):30-48. [QxMD MEDLINE Link].

29. Wen BC, Hussey DH, Staples J, et al. A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int J Radiat Oncol Biol Phys. 1989 Jan. 16(1):17-24. [QxMD MEDLINE Link].

30. Sughrue ME, Yang I, Kane AJ, Fang S, Clark AJ, Aranda D. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011 Feb. 101(3):463-76. [QxMD MEDLINE Link].

31. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010 Apr. 28 (4):E10. [QxMD MEDLINE Link].

32. Murphy ES, Chao ST, Angelov L, Vogelbaum MA, Barnett G, Jung E, et al. Radiosurgery for Pediatric Brain Tumors. Pediatr Blood Cancer. 2016 Mar. 63 (3):398-405. [QxMD MEDLINE Link].

33. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev. 2000 Jun. 21 (3):215-44. [QxMD MEDLINE Link].

34. Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2006 May. 64 (5):556-60. [QxMD MEDLINE Link].

35. Rohrer TR, Langer T, Grabenbauer GG, Buchfelder M, Glowatzki M, Dörr HG. Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children. J Pediatr Endocrinol Metab. 2010 Sep. 23 (9):935-42. [QxMD MEDLINE Link].

36. Smith TR, Cote DJ, Jane JA Jr, Laws ER Jr. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study. J Neurosurg Pediatr. 2016 Oct. 18 (4):408-412. [QxMD MEDLINE Link].

37. Manley PE, McKendrick K, McGillicudy M, et al. Sleep dysfunction in long term survivors of craniopharyngioma. J Neurooncol. 2012 Jul. 108(3):543-9. [QxMD MEDLINE Link].

38. Chandrakasan S, Sood S, Ham S, Moltz K, Frey MJ, Rajpurkar M. Risk factors and management of deep venous thrombosis in children following post-surgical hypopituitarism in craniopharyngioma. Pediatr Blood Cancer. 2011 Jul 15. 57(1):175-7. [QxMD MEDLINE Link].

39. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010 Apr. 28(4):E10. [QxMD MEDLINE Link].

40. Rodriguez FJ, Scheithauer BW, Tsunoda S, Kovacs K, Vidal S, Piepgras DG. The spectrum of malignancy in craniopharyngioma. Am J Surg Pathol. 2007 Jul. 31(7):1020-8. [QxMD MEDLINE Link].

41. Yosef L, Ekkehard KM, Shalom M. Giant craniopharyngiomas in children: short- and long-term implications. Childs Nerv Syst. 2016 Jan. 32 (1):79-88. [QxMD MEDLINE Link].

42. Liu AK, Bagrosky B, Fenton LZ, Gaspar LE, Handler MH, McNatt SA. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer. 2008 Oct 20. 52(2):227-230. [QxMD MEDLINE Link].

43. Jane JA Jr, Kiehna E, Payne SC, Early SV, Laws ER Jr. Early outcomes of endoscopic transsphenoidal surgery for adult craniopharyngiomas. Neurosurg Focus. 2010 Apr. 28(4):E9. [QxMD MEDLINE Link].

44. Campbell PG, McGettigan B, Luginbuhl A, Yadla S, Rosen M, Evans JJ. Endocrinological and ophthalmological consequences of an initial endonasal endoscopic approach for resection of craniopharyngiomas. Neurosurg Focus. 2010 Apr. 28(4):E8. [QxMD MEDLINE Link].

45. Allen ED, Byrd SE, Darling CF, et al. The clinical and radiological evaluation of primary brain tumors in children, Part I: Clinical evaluation. J Natl Med Assoc. 1993 Jun. 85(6):445-51. [QxMD MEDLINE Link].

46. Blethen SL. Growth in children with a craniopharyngioma. Pediatrician. 1987. 14(4):242-5. [QxMD MEDLINE Link].

47. Cavalheiro S, Dastoli PA, Silva NS, et al. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst. 2005 Aug. 21(8-9):719-24. [QxMD MEDLINE Link].

48. Dunbar SF, Tarbell NJ, Kooy HM, et al. Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys. 1994 Oct 15. 30(3):531-9. [QxMD MEDLINE Link].

49. Fisher PG, Jenab J, Gopldthwaite PT, et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst. 1998 Oct. 14(10):558-63. [QxMD MEDLINE Link].

50. Garrè ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007 Aug. 19(4):471-9. [QxMD MEDLINE Link].

51. Gonzales-Portillo G, Tomita T. The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases. Neurosurgery. 1998 Apr. 42(4):917-21; discussion 921-2. [QxMD MEDLINE Link].

52. Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys. 1999 May 1. 44(2):255-63. [QxMD MEDLINE Link].

53. Kollias SS, Barkovich AJ, Edwards MS. Magnetic resonance analysis of suprasellar tumors of childhood. Pediatr Neurosurg. 1991-92. 17(6):284-303. [QxMD MEDLINE Link].

54. Rajan B, Ashley S, Thomas DG, et al. Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys. 1997 Feb 1. 37(3):517-21. [QxMD MEDLINE Link].

55. Regine WF, Kramer S. Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys. 1992. 24(4):611-7. [QxMD MEDLINE Link].

56. Regine WF, Mohiuddin M, Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol. 1993 Apr. 27(1):13-21. [QxMD MEDLINE Link].

57. Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg. 1994. 21 Suppl 1:39-43. [QxMD MEDLINE Link].

58. Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurol Clin. 1991 May. 9(2):453-65. [QxMD MEDLINE Link].

59. Shiminski-Maher T, Rosenberg M. Late effects associated with treatment of craniopharyngiomas in childhood. J Neurosci Nurs. 1990 Aug. 22(4):220-6. [QxMD MEDLINE Link].

60. Tomita T. Management of craniopharyngiomas in children. Pediatr Neurosci. 1988. 14(4):204-11. [QxMD MEDLINE Link].

61. Tomita T, McLone DG. Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg. 1993. 19(1):6-14. [QxMD MEDLINE Link].

62. Tsao MN, Wara WM, Larson DA. Radiation therapy for benign central nervous system disease. Semin Radiat Oncol. 1999 Apr. 9(2):120-33. [QxMD MEDLINE Link].

63. Wilson CB. Diagnosis and surgical treatment of childhood brain tumors. Cancer. 1975 Mar. 35(3 suppl):950-6. [QxMD MEDLINE Link].

Sara R Kreimer Barron, MD Clinical Assistant Professor, Department of Pediatric Hematology-Oncology, Lucile Packard Children's Hospital, Stanford University School of Medicine

Sara R Kreimer Barron, MD is a member of the following medical societies: Alpha Omega Alpha, American Society of Hematology, American Society of Pediatric Hematology/Oncology

Disclosure: Nothing to disclose.

Joseph L Lasky, III, MD Pediatric Hematologist/Oncologist, Children’s Specialty Center of Nevada; Division Chief, Physician Specialist, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Harbor-UCLA Medical Center; Investigator, Los Angeles Biomedical Research Institute (LABiomed)

Joseph L Lasky, III, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Pediatric Hematology/Oncology, Children's Oncology Group, Society for Neuro-Oncology

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Bayer, Octapharma<br/>Received grant/research funds from Novo-Nordisk for site pi; Received grant/research funds from Emmaus for site pi; Received consulting fee from Octapharma for consulting; Received consulting fee from CSL Behring for consulting; Received grant/research funds from Novartis for site pi.

Kathleen M Sakamoto, MD, PhD Shelagh Galligan Professor, Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine

Kathleen M Sakamoto, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Society of Hematology, American Society of Pediatric Hematology/Oncology, International Society for Experimental Hematology, Society for Pediatric Research, Western Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Timothy P Cripe, MD, PhD, FAAP Chief, Division of Hematology/Oncology/BMT, Gordon Teter Endowed Chair in Pediatric Cancer, Nationwide Children's Hospital; Professor of Pediatrics, Ohio State University College of Medicine

Timothy P Cripe, MD, PhD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American Association for Cancer Research, American Pediatric Society, American Society of Gene and Cell Therapy, American Society of Pediatric Hematology/Oncology, Connective Tissue Oncology Society, Society for Pediatric Research, Children's Oncology Group

Disclosure: Nothing to disclose.

Vikramjit S Kanwar, MBBS, MBA, MRCP(UK) Professor Emeritus of Pediatrics, Albany Medical College; Chief of Pediatric Oncology, Homi Bhabha Cancer Hospital, Varanasi, India

Vikramjit S Kanwar, MBBS, MBA, MRCP(UK) is a member of the following medical societies: Children's Oncology Group, Indian Academy of Pediatrics, International Society of Pediatric Oncology

Disclosure: Nothing to disclose.

Jerry L Barker, Jr, MD Staff Physician, Clinical Associate Professor of Radiation Oncology, Department of Radiation Oncology, University of Texas Southwestern Moncrief Cancer Center

Jerry L Barker, Jr, MD is a member of the following medical societies: American Society for Therapeutic Radiology and Oncology

Disclosure: Nothing to disclose.

Samuel Gross, MD Professor Emeritus, Department of Pediatrics, University of Florida College of Medicine; Clinical Professor, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine; Adjunct Professor, Department of Pediatrics, Duke University School of Medicine

Samuel Gross, MD is a member of the following medical societies: American Association for Cancer Research, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, American Society of Hematology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

B-Chen Wen, MD Professor, Department of Radiology, Division of Radiation Oncology, University of Iowa Hospitals and Clinics

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article